A receptor-independent effect of estrone sulfate on the hERG channel

Journal of Pharmacological Sciences

Volumn 109, Issue 1, 2009, Pages 152-156

  Kakusaka, Shoko ^a,b   Asayama, Mahoko ^a,c   Kaihara, Asami ^a   Sasano, Tetsuo ^a   Suzuki, Takeshi ^b   Kurokawa, Junko ^a   Furukawa, Tetsushi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Estrogen; Heart; K+ channel (hERG)

Indexed keywords

ESTRIOL; ESTRONE; ESTRONE SULFATE; POTASSIUM CHANNEL HERG;

ARTICLE; CELL STRAIN HEK293; CHANNEL GATING; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; ION CURRENT; PATCH CLAMP; SIGNAL TRANSDUCTION;

EID: 58649098190     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08257SC     Document Type: Article

References (15)

1. James AF, Choisy SC, Hancox JC. Recent advances in understanding sex differences in cardiac repolarization. Prog Biophys Mol Biol. 2007;94:265-319.
2. Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA. 1993;270:2590-2597.
3. + channel structure-activity relationships and mechanisms of drug-induced QT prolongation. Annu Rev Pharmacol Toxicol. 2003;43:441-461.
4. Bazett HC. The time relations of the blood-pressure changes after excision of the adrenal glands, with some observations on blood volume changes. J Physiol. 1920;53:320-339.
5. Furukawa T, Kurokawa J. Regulation of cardiac ion channels via non-genomic action of sex steroid hormones: Implication for the gender difference in cardiac arrhythmias. Pharmacol Ther. 2007; 115:106-115.
6. Bai CX, Kurokawa J, Tamagawa M, Nakaya H, Furukawa T. Nontranscriptional regulation of cardiac repolarization currents by testosterone. Circulation. 2005;112:1701-1710.
7. Nakamura H, Kurokawa J, Bai CX, Asada K, Xu J, Oren RV, et al. Progesterone regulates cardiac repolarization through a nongenomic pathway: an in vitro patch-clamp and computational modeling study. Circulation. 2007;116:2913-2922.
8. Rodriguez I, Kilborn MJ, Liu XK, Pezzullo JC, Woosley RL. Drug-induced QT prolongation in women during the menstrual cycle. JAMA. 2001;285:1322-1326.
9. Kadish AH, Greenland P, Limacher MC, Frishman WH, Daugherty SA, Schwartz JB. Estrogen and progestin use and the QT interval in postmenopausal women. Ann Noninvasive Electrocardiol. 2004;9:366-374.
10. Drici MD, Burklow TR, Haridasse V, Glazer RI, Woosley RL. Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation. 1996;94:1471-1474.
11. Kr channels and drug-induced prolongation of cardiac repolarization. J Physiol. 2008;586:2961-2973.
12. Lehmann MH, Hardy S, Archibald D, Quart B, MacNeil DJ. Sex difference in risk of torsade de pointes with d,l-sotalol. Circulation. 1996;94:2535-2541.
13. Pasqualini JR, Chetrite G, Blacker C, Feinstein MC, Delalonde L, Talbi M, et al. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. J Clin Endocrinol Metab. 1996;81:1460-1464.
14. Giton F, Valleix A, Boudou P, Villette JM, Belanger A, Galons H, et al. Specific radioimmunoassay of estrone sulfate. Application to measurement in male plasma. J Steroid Biochem Mol Biol. 2002;81:85-94.
15. Valverde MA, Rojas P, Amigo J, Cosmelli D, Orio P, Bahamonde MI, et al. Acute activation of maxi-K channels (hSlo) by estradiol binding to the b subunit. Science. 1999;285:1929-1931.